<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37025205</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Association between serologically confirmed COVID-19 infection and cognitive functioning in community dwelling older adults.</ArticleTitle><Pagination><StartPage>1093852</StartPage><MedlinePgn>1093852</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1093852</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2023.1093852</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">COVID-19 infection can impact the central nervous system, and is often associated with cognitive decline. However, there are no studies linking serologically confirmed COVID-19 infection with objectively assessed cognitive functioning. We explored whether presence of SARS-CoV-2 antibodies account for variability in participants' scores on a neuropsychological assessment.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this cross-sectional study participants were 657 (mean age&#x2009;=&#x2009;72.97; SD&#x2009;=&#x2009;6.07&#x2009;years; women&#x2009;=&#x2009;47.7%) individuals randomly selected from the general population of the canton of Zurich and included in the Corona Immunitas study. We conducted serological tests between October 2020 and May 2021 to detect and quantify SARS-CoV-2 antibodies in peripheral venous blood samples. We assessed cognitive function, vaccination status (vaccinated; not vaccinated), number of health conditions, and demographic variables between January and August 2021. We studied the association between seropositivity and global cognitive function and five cognitive domains (language expression, language comprehension, temporal orientation, spatial orientation, and memory) with linear regression models. Based on SARS-CoV-2 antibodies and vaccination status, we stratified participants into three groups: No SARS-CoV-2 antibodies (<i>N</i>&#x2009;=&#x2009;402); SARS-CoV-2 antibodies due to vaccination (<i>N</i>&#x2009;=&#x2009;218); history of SARS-CoV-2 infection and no vaccination (<i>N</i>&#x2009;=&#x2009;37).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In the regression model adjusted for age, sex, educational level, and number of health conditions, compared to those without SARS-CoV-2 antibodies, those with SARS-CoV-2 antibodies due to vaccination had better global cognitive functioning (Standardized beta&#x2009;=&#x2009;0.10; 95% CI&#x2009;=&#x2009;0.02; 0.17), and those with SARS-CoV-2 antibodies due to infection had poorer cognitive functioning (Standardized beta&#x2009;=&#x2009;-0.10; 95% CI&#x2009;=&#x2009;-0.18; -0.03). Regarding cognitive domains, compared to those without SARS-CoV-2 antibodies, those with SARS-CoV-2 antibodies due to infection scored more poorly on language comprehension and temporal orientation, and those with SARS-CoV-2 antibodies due to vaccination scored better on memory.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">By linking serologically confirmed presence of SARS-CoV-2 antibodies to poorer global cognitive functioning in community dwelling older adults we strengthen existing evidence in support of cognitive decline related to COVID-19. Given the large number of infected older adults, and the endurance of the pandemic, our results highlight the need to address COVID-19 related cognitive decline in the clinical and public health areas of prevention, diagnosis, and treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sabatini, Pacifico, Frei, Graf, Puhan and Albanese.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serena</LastName><ForeName>Sabatini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deborah</LastName><ForeName>Pacifico</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Biomedical Sciences, Institute of Public Health (IPH), Universit&#xe0; della Svizzera italiana, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anja</LastName><ForeName>Frei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Epidemiology Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gwendolyn</LastName><ForeName>Graf</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Epidemiology Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puhan</LastName><ForeName>Milo A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Epidemiology Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albanese</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Biomedical Sciences, Institute of Public Health (IPH), Universit&#xe0; della Svizzera italiana, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2 antibodies</Keyword><Keyword MajorTopicYN="N">cognitive covid</Keyword><Keyword MajorTopicYN="N">cognitive decline</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">serological assessment</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>2</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37025205</ArticleId><ArticleId IdType="pmc">PMC10070998</ArticleId><ArticleId IdType="doi">10.3389/fneur.2023.1093852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Coronavirus disease (COVID-19) 2023. Available at: https://www.who.int/health-topics/coronavirus#tab=tab_3</Citation></Reference><Reference><Citation>World Health Organization . WHO coronavirus (COVID-19) dashboard 2023. Available at: https://covid19.who.int</Citation></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. (2022) 11:269. doi: 10.3390/pathogens11020269, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Puhan MA, Raineri A, Gao M, West E, B&#xfc;rzle O. Long COVID: Evolving definitions, burden of disease and socio-economic consequences. Swiss School of Public Health. (2022).</Citation></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. . Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and&#x2265; 65 years&#x2014;United States, march 2020&#x2013;November 2021. Morb Mortal Wkly Rep. (2022) 71:713&#x2013;7. doi: 10.15585/mmwr.mm7121e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. (2021) 9:129. doi: 10.1016/S2213-2600(21)00031-X, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Tao M, Shang L, Liu Y, Pan G, Jin Y, et al. . Assessment of sequelae of COVID-19 nearly 1 year after diagnosis. Front Med. (2021) 8:8. doi: 10.3389/fmed.2021.717194</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.717194</ArticleId><ArticleId IdType="pmc">PMC8649686</ArticleId><ArticleId IdType="pubmed">34888318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, Menges D, Anagnostopoulos A, Domenghino A, Aschmann HE, Frei A, et al. . Natural course of post COVID-19 condition and implications for trial design and outcome selection: a population-based longitudinal cohort study. medRxiv. (2022)</Citation></Reference><Reference><Citation>Bertuccelli M, Ciringione L, Rubega M, Bisiacchi P, Masiero S, Del Felice A. Cognitive impairment in people with previous COVID-19 infection: a scoping review. Cortex. (2022) 154:212&#x2013;30. doi: 10.1016/j.cortex.2022.06.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.06.002</ArticleId><ArticleId IdType="pmc">PMC9187867</ArticleId><ArticleId IdType="pubmed">35780756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K, Chan D. The emergence of cognitive COVID. World Psychiatry. (2021) 20:52&#x2013;3. doi: 10.1002/wps.20837, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20837</ArticleId><ArticleId IdType="pmc">PMC7801840</ArticleId><ArticleId IdType="pubmed">33432769</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19&#x2014;a review on objective test data. Front Neurol. (2021) 12:699582. doi: 10.3389/fneur.2021.699582, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J, Humkamp K, Hohenfeld C, Rust MI, Ermis U, Dreher M, et al. . Long COVID-19: objectifying most self-reported neurological symptoms. Ann. Clin Transl Neurol. (2022) 9:141&#x2013;54. doi: 10.1002/acn3.51496, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Makizako H, Nakai Y, Shiratsuchi D, Akanuma T, Yokoyama K, Matsuzaki-Kihara Y, et al. . Perceived declining physical and cognitive fitness during the COVID-19 state of emergency among community-dwelling Japanese old-old adults. Geriatr Gerontol Int. (2021) 21:364&#x2013;9. doi: 10.1111/ggi.14140, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.14140</ArticleId><ArticleId IdType="pmc">PMC8013798</ArticleId><ArticleId IdType="pubmed">33576180</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, Valles-Salgado M, Delgado-&#xc1;lvarez A, Yus M, G&#xf3;mez-Ruiz N, Jorquera M, et al. . Cognitive dysfunction associated with COVID-19: a comprehensive neuropsychological study. J Psychiatr Res. (2022) 150:40&#x2013;6. doi: 10.1016/j.jpsychires.2022.03.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-S&#xe1;nchez C, Calabria M, Grunden N, Pons C, Arroyo JA, G&#xf3;mez-Anson B, et al. . Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. (2022) 12:e2508. doi: 10.1002/brb3.2508, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2508</ArticleId><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W, et al. . Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. (2022) 18:1047&#x2013;66. doi: 10.1002/alz.12644, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Anstey KJ, Peters R, Clare L, Lautenschlager NT, Dodge HH, Barnes DE, et al. . Joining forces to prevent dementia: the international research network on dementia prevention (IRNDP). Int Psychogeriatr. (2017) 29:1757&#x2013;60. doi: 10.1017/S1041610217001685, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610217001685</ArticleId><ArticleId IdType="pmc">PMC5873600</ArticleId><ArticleId IdType="pubmed">28899450</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . (2023). Dementia, Key facts. Available at: https://www.who.int/news-room/fact-sheets/detail/dementia.</Citation></Reference><Reference><Citation>Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A, et al. . COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. (2021) 16:e0246590. doi: 10.1371/journal.pone.0246590, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. (2022) 434:120162. doi: 10.1016/j.jns.2022.120162, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde Cardona G, Quintana P&#xe1;jaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: mechanisms and manifestations. J Neurol Sci. (2020) 412:116824. doi: 10.1016/j.jns.2020.116824, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116824</ArticleId><ArticleId IdType="pmc">PMC7141641</ArticleId><ArticleId IdType="pubmed">32299010</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care. (2021) 34:1062&#x2013;71. doi: 10.1007/s12028-020-01049-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-01049-4</ArticleId><ArticleId IdType="pmc">PMC7358290</ArticleId><ArticleId IdType="pubmed">32661794</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. J Alzheimers Dis. (2020) 76:3&#x2013;19. doi: 10.3233/JAD-200581, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200581</ArticleId><ArticleId IdType="pmc">PMC7660990</ArticleId><ArticleId IdType="pubmed">32538857</ArticleId></ArticleIdList></Reference><Reference><Citation>Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. (2020) 77:1028&#x2013;9. doi: 10.1001/jamaneurol.2020.2125, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2125</ArticleId><ArticleId IdType="pubmed">32469400</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. (2020) 395:e109. doi: 10.1016/S0140-6736(20)31282-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31282-4</ArticleId><ArticleId IdType="pmc">PMC7272176</ArticleId><ArticleId IdType="pubmed">32505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. . Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. (2020) 324:259&#x2013;69. doi: 10.1001/jama.2020.10369, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. (2020) 26:499&#x2013;501. doi: 10.1111/cns.13372, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13372</ArticleId><ArticleId IdType="pmc">PMC7163592</ArticleId><ArticleId IdType="pubmed">32266761</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host&#x2013;virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. (2020) 11:995&#x2013;8. doi: 10.1021/acschemneuro.0c00122, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruiyot I. Comment on &#x201c;encephalopathy in patients with COVID-19: A review&#x201d;. J Med Virol. (2020) 93:149&#x2013;50. doi: 10.1002/jmv.26238</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26238</ArticleId><ArticleId IdType="pmc">PMC7361767</ArticleId><ArticleId IdType="pubmed">32603476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Jolkkonen J, Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: similarities with other coronaviruses. Neurosci Biobehav Rev. (2020) 119:184&#x2013;93. doi: 10.1016/j.neubiorev.2020.10.012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7571477</ArticleId><ArticleId IdType="pubmed">33091416</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Lendemeijer B, Leijten L, Embregts CWE, Rockx B, Kushner SA, et al. . Replication kinetics, cell tropism, and associated immune responses in SARS-CoV-2-and H5N1 virus-infected human induced pluripotent stem cell-derived neural models. Msphere. (2021) 6:e0027021. doi: 10.1128/mSphere.00270-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00270-21</ArticleId><ArticleId IdType="pmc">PMC8265642</ArticleId><ArticleId IdType="pubmed">34160239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullen CK, Hogberg HT, Bahadirli-Talbott A, Bishai WR, Hartung T, Keuthan C, et al. . Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2. ALTEX. (2020) 37:665&#x2013;71. doi: 10.14573/altex.2006111, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.14573/altex.2006111</ArticleId><ArticleId IdType="pubmed">32591839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B-Z, Chu H, Han S, Shuai H, Deng J, Hu Y-F, et al. . SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. (2020) 30:928&#x2013;31. doi: 10.1038/s41422-020-0390-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0390-x</ArticleId><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Anstey KJ, Eramudugolla R, Hosking DE, Lautenschlager NT, Dixon RA. Bridging the translation gap: from dementia risk assessment to advice on risk reduction. J Prev Alzheimers Dis. (2015) 2:189&#x2013;98. doi: 10.14283/jpad.2015.75, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2015.75</ArticleId><ArticleId IdType="pmc">PMC4568745</ArticleId><ArticleId IdType="pubmed">26380232</ArticleId></ArticleIdList></Reference><Reference><Citation>Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, et al. . Age-associated cognitive decline. Br Med Bull. (2009) 92:135&#x2013;52. doi: 10.1093/bmb/ldp033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldp033</ArticleId><ArticleId IdType="pubmed">19776035</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera MR, Fiabane E, Pain D, Aiello EN, Radici A, Ottonello M, et al. . Clinical features and cognitive sequelae in COVID-19: a retrospective study on N= 152 patients. Neurol Sci. (2022) 43:45&#x2013;50. doi: 10.1007/s10072-021-05744-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05744-8</ArticleId><ArticleId IdType="pmc">PMC8591589</ArticleId><ArticleId IdType="pubmed">34779965</ArticleId></ArticleIdList></Reference><Reference><Citation>Razai MS, Chaudhry UAR, Doerholt K, Bauld L, Majeed A. COVID-19 vaccination hesitancy. BMJ. (2021) 373:n1138. doi: 10.1136/bmj.n1138</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1138</ArticleId><ArticleId IdType="pubmed">34016653</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadda M, Suggs LS, Albanese E. Willingness to vaccinate against Covid-19: a qualitative study involving older adults from southern Switzerland. Vaccine X. (2021) 8:100108. doi: 10.1016/j.jvacx.2021.100108</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2021.100108</ArticleId><ArticleId IdType="pmc">PMC8279929</ArticleId><ArticleId IdType="pubmed">34308329</ArticleId></ArticleIdList></Reference><Reference><Citation>Desson Z, Kauer L, Otten T, Peters JW, Paolucci F. Finding the way forward: COVID-19 vaccination progress in Germany, Austria and Switzerland. Health Policy Technol. (2022) 11:100584. doi: 10.1016/j.hlpt.2021.100584, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2021.100584</ArticleId><ArticleId IdType="pmc">PMC8627596</ArticleId><ArticleId IdType="pubmed">34868834</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hooren SAH, Valentijn AM, Bosma H, Ponds RWHM, MPJ VB, Jolles J. Cognitive functioning in healthy older adults aged 64&#x2013;81: a cohort study into the effects of age, sex, and education. Aging Neuropsychol Cognit. (2007) 14:40&#x2013;54. doi: 10.1080/138255890969483, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/138255890969483</ArticleId><ArticleId IdType="pubmed">17164189</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty GD, Deary IJ, Fawns-Ritchie C, Gale CR, Altschul D. Pre-pandemic cognitive function and COVID-19 vaccine hesitancy: cohort study. Brain Behav Immun. (2021) 96:100&#x2013;5. doi: 10.1016/j.bbi.2021.05.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.05.016</ArticleId><ArticleId IdType="pmc">PMC8133799</ArticleId><ArticleId IdType="pubmed">34022372</ArticleId></ArticleIdList></Reference><Reference><Citation>West EA, Anker D, Amati R, Richard A, Wisniak A, Butty A, et al. . Corona immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health. (2020) 65:1529&#x2013;48. doi: 10.1007/s00038-020-01494-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-020-01494-0</ArticleId><ArticleId IdType="pmc">PMC7584867</ArticleId><ArticleId IdType="pubmed">33098441</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart R, Guerchet M, Prince M. Development of a brief assessment and algorithm for ascertaining dementia in low-income and middle-income countries: the 10/66 short dementia diagnostic schedule. BMJ Open. (2016) 6:e010712. doi: 10.1136/bmjopen-2015-010712, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-010712</ArticleId><ArticleId IdType="pmc">PMC4885443</ArticleId><ArticleId IdType="pubmed">27225649</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. (2009) 42:377&#x2013;81. doi: 10.1016/j.jbi.2008.08.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. . The REDCap consortium: building an international community of software platform partners. J Biomed Inform. (2019) 95:103208. doi: 10.1016/j.jbi.2019.103208, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall KS, Hendrie HC, Brittain HM, Norton JA, Rodgers DD, Prince CS, et al. . The development of a dementia screening interview in 2 distinct languages. Int J Methods Psychiatr Res. (1993) 3:1&#x2013;28.</Citation></Reference><Reference><Citation>Fenwick C, Croxatto A, Coste AT, Pojer F, Andr&#xe9; C, Pellaton C, et al. . Changes in SARS-CoV-2 spike versus nucleoprotein antibody responses impact the estimates of infections in population-based seroprevalence studies. J Virol. (2021) 95:e01828&#x2013;10. doi: 10.1128/JVI.01828-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01828-20</ArticleId><ArticleId IdType="pmc">PMC7925109</ArticleId><ArticleId IdType="pubmed">33144321</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenwick C, Turelli P, Pellaton C, Farina A, Campos J, Raclot C, et al. . A high-throughout cell-and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma. Sci Transl Med. (2021) 13:eabi8452. doi: 10.1126/scitranslmed.abi8452</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi8452</ArticleId><ArticleId IdType="pmc">PMC9835890</ArticleId><ArticleId IdType="pubmed">34257144</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates; (1988).</Citation></Reference><Reference><Citation>StataCorp . Stata statistical software: Release 16. College Station, TX: StataCorp LLC. (2017).</Citation></Reference><Reference><Citation>Borsche M, Reichel D, Fellbrich A, Lixenfeld AS, Rahm&#xf6;ller J, Vollstedt E-J, et al. . Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19. Neurol Res Pract. (2021) 3:1&#x2013;3. doi: 10.1186/s42466-021-00135-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-021-00135-y</ArticleId><ArticleId IdType="pmc">PMC8214919</ArticleId><ArticleId IdType="pubmed">34148546</ArticleId></ArticleIdList></Reference><Reference><Citation>Shir D, Day GS. Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019. Curr Opin Neurol. (2022) 35:212&#x2013;9. doi: 10.1097/WCO.0000000000001033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001033</ArticleId><ArticleId IdType="pmc">PMC8896289</ArticleId><ArticleId IdType="pubmed">35102125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajo AT, Espiritu AI, Apor ADAO, Jamora RDG. Neuropathologic findings of patients with COVID-19: a systematic review. Neurol Sci. (2021) 42:1255&#x2013;66. doi: 10.1007/s10072-021-05068-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05068-7</ArticleId><ArticleId IdType="pmc">PMC7822400</ArticleId><ArticleId IdType="pubmed">33483885</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Saez J, Lauer SA, Kaiser L, Regard S, Delaporte E, Guessous I, et al. . Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. (2021) 21:e69&#x2013;70. doi: 10.1016/S1473-3099(20)30584-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30584-3</ArticleId><ArticleId IdType="pmc">PMC7833057</ArticleId><ArticleId IdType="pubmed">32679085</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Global action plan on the public health response to dementia 2017&#x2013;2025. Geneva: World Health Organization. (2017).</Citation></Reference><Reference><Citation>Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. . Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. (2020) 396:413&#x2013;46. doi: 10.1016/S0140-6736(20)30367-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType="pmc">PMC7392084</ArticleId><ArticleId IdType="pubmed">32738937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tampi RR, Forester BP, Agronin M. Aducanumab: Evidence from clinical trial data and controversies. Drugs Context. (2021) 10:1&#x2013;9. doi: 10.7573/dic.2021-7-3</Citation><ArticleIdList><ArticleId IdType="doi">10.7573/dic.2021-7-3</ArticleId><ArticleId IdType="pmc">PMC8491638</ArticleId><ArticleId IdType="pubmed">34650610</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T, Varnai R, Schranz D, Zavori L, Peterfi Z, Sipos D, et al. . Severe fatigue and memory impairment are associated with lower serum level of anti-SARS-CoV-2 antibodies in patients with post-COVID symptoms. J Clin Med. (2021) 10:4337. doi: 10.3390/jcm10194337, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter D, Braw Y. COVID-19: impact of diagnosis threat and suggestibility on subjective cognitive complaints. Int J Clin Health Psychol. (2022) 22:100253. doi: 10.1016/j.ijchp.2021.100253, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijchp.2021.100253</ArticleId><ArticleId IdType="pmc">PMC8142858</ArticleId><ArticleId IdType="pubmed">34054975</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel R, Savrides I, Cahalan C, Doulatani G, O&#x2019;Dell MW, Toglia J, et al. . Cognitive impairment and functional change in COVID-19 patients undergoing inpatient rehabilitation. Int J Rehabil Res. (2021) 44:285&#x2013;8. doi: 10.1097/MRR.0000000000000483, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MRR.0000000000000483</ArticleId><ArticleId IdType="pubmed">34156035</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. (1975) 12:189&#x2013;98. doi: 10.1016/0022-3956(75)90026-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson J. The Montreal cognitive assessment (MoCA). Occup Med. (2015) 65:764&#x2013;5. doi: 10.1093/occmed/kqv078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqv078</ArticleId><ArticleId IdType="pubmed">26644445</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Mostafavi H, Ng WH, Freitas JR, King NJC, Zaid A, et al. . The Delta SARS-CoV-2 variant of concern induces distinct pathogenic patterns of respiratory disease in K18-hACE2 transgenic mice compared to the ancestral strain from Wuhan. MBio. (2022) 13:e00683-22. doi: 10.1128/mbio.00683-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00683-22</ArticleId><ArticleId IdType="pmc">PMC9239116</ArticleId><ArticleId IdType="pubmed">35420469</ArticleId></ArticleIdList></Reference><Reference><Citation>Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, et al. . SARS-CoV-2: current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol. (2021) 101:108232. doi: 10.1016/j.intimp.2021.108232, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108232</ArticleId><ArticleId IdType="pmc">PMC8519814</ArticleId><ArticleId IdType="pubmed">34673335</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkan E. COVID-19: structural considerations for virus pathogenesis, therapeutic strategies and vaccine design in the novel SARS-CoV-2 variants era. Mol Biotechnol. (2021) 63:885&#x2013;97. doi: 10.1007/s12033-021-00353-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12033-021-00353-4</ArticleId><ArticleId IdType="pmc">PMC8213040</ArticleId><ArticleId IdType="pubmed">34145550</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>